Gene Editing Might Alter Our DNA. It Might Destroy Our Humanity, Too.
By Mark Buchanan,
Bloomberg
| 11. 25. 2019
Biologists recently revealed a new form of the gene-editing tool known as Crispr that allows researchers to make precise changes to almost any element of DNA, permanently altering cellular biochemistry. It could help treat tens of thousands of diseases linked to variations in a single gene and lead to the creation of better antibiotics.
The latest development, called prime editing, is more accurate than older Crispr methods, which sometimes alter genomic DNA in the wrong places. The new method will be a boon to the least contentious kind of gene editing — gene therapy — which introduces genetic changes only within the body’s somatic or nonreproductive cells. One such method is already in clinical trials to treat Huntington’s disease, in which a genetic mutation leads to production of an abnormal protein in brain cells.
As gene-editing technology races ahead, scientists are agonizing over ethical issues. How, for example, can they ensure that treatments don’t cause more problems than they fix? Some genetic variants that seem clearly beneficial — lowering the risk of heart disease, for example — could have other...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...